pharmaphorum November 25, 2020
Pharmaceutical marketing budgets are going through a period of readjustment as companies explore and exploit a myriad of different digital channels to deliver content to, and engage with, their doctors and other audiences.
The average allocation to digital channels with marketing budgets has doubled since 2016, up to 34% for 2020 according to Indegene research, and over a third of companies expect digital budget allocations to increase by more than 50% over the next three years.
But making effective use of these resources to reach doctors around the world increasingly remains a challenge for pharma companies.
M3’s new Engaging Doctors Around the Globe whitepaper explores the most pressing challenges that pharma will encounter when planning and delivering a global digital...